Manus Neurodynamica is radically innovating health care management in the emerging field of diagnostics for neuromotor impairments, initially in Parkinson’s Disease.

Its principal product, the Neuromotor Pen™ for the diagnosis and monitoring of neuromotor impairments, is a non-invasive, patented technology that records and analyses upper-limb and hand motion to assess the underlying neuromotor processes, particularly for patients with Parkinson’s Disease.

The device enables users to distinguish Parkinson’s Disease patients from elderly patients with a benign deterioration win motor skill with a diagnosis accuracy of 90% – enabling early intervention which is vital to successful treatment outcome.